{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:12:01Z","timestamp":1790097121998,"version":"4.0.1"},"reference-count":30,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Asia Pac J Public Health"],"abstract":"<jats:p>The COVID-19 pandemic underscores the need to promote and protect well-being by strengthening prevention, preparedness and response to global health threats. It also demonstrated the need for coordinated national and international efforts, particularly to ensure equitable access to vaccines during public health crises. Malaysia has implemented robust pandemic preparedness measures, although its COVID-19 experience highlighted the need to improve access to life-saving vaccines and to take urgent action towards achieving vaccine security to safeguard public health. Recent initiatives have demonstrated a commitment to this goal, but additional efforts are required to ensure sustainability. In this article, we examine Malaysia\u2019s efforts to strengthen vaccine security and the role of international partnerships in supporting this agenda. Malaysia has significant opportunities to promote its biopharmaceutical industry and advance vaccine security. However, the long-term success of these efforts will depend on sustainable investment, stronger coordination, and strategic alignment between domestic capability and international partnership-building.<\/jats:p>","DOI":"10.1177\/10105395261481894","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:40:01Z","timestamp":1789807201000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Advancing Vaccine Security in Pandemic Preparedness: Malaysia\u2019s Growing Role, Opportunities and Challenges"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6344-7123","authenticated-orcid":false,"given":"Nurhafiza","family":"Md Hamzah","sequence":"first","affiliation":[{"name":"National Institutes of Health, Setia Alam, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemilah","family":"Mahmood","sequence":"additional","affiliation":[{"name":"Sunway University, Petaling Jaya, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elil","family":"Renganathan","sequence":"additional","affiliation":[{"name":"Monash University, Subang Jaya, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jped.2022.11.002"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/10105395231223284"},{"key":"e_1_3_2_4_2","unstructured":"World Health Organization. Defining Access to Countermeasures: landscape report. Executive Summary. World Health Organization; 2024. Accessed July 2 2026. https:\/\/www.who.int\/"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/10105395251234567"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.950411"},{"key":"e_1_3_2_7_2","unstructured":"World Health Organization. Vaccine security. World Health Organization. Accessed March 12 2026. https:\/\/www.who.int\/southeastasia\/activities\/vaccine-security"},{"key":"e_1_3_2_8_2","unstructured":"Regionalized Vaccine Manufacturing Collaborative. Regionalized Vaccine Manufacturing Collaborative strategy_2024-27. Regionalized Vaccine Manufacturing Collaborative. Published July 29 2024. Accessed August 1 2025. https:\/\/static.rvmc.net\/downloads\/2024-07\/RVMC_Strategy_2024-27_290724.pdf"},{"key":"e_1_3_2_9_2","unstructured":"Mutasa R Ramana G Newmarch G et al. ASEAN Regional Vaccine Manufacturing and Development. World Bank Group; 2023. Accessed February 2 2026. https:\/\/openknowledge.worldbank.org\/server\/api\/core\/bitstreams\/d3ab6559-6040-4532-b592-1953a309407f\/content"},{"key":"e_1_3_2_10_2","unstructured":"Gavi the Vaccine Alliance. More than US$ 1.8 billion in support for African vaccine manufacturing catching up missed children and pandemic preparedness approved as Gavi Board steps up efforts to tackle backsliding and fight health emergencies. Gavi the Vaccine Alliance. Published December 7 2023. Accessed August 1 2025. https:\/\/www.gavi.org\/news\/media-room\/initiatives-african-vaccine-manufacturing-approved-gavi-board"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00183-0"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","unstructured":"Muangchana C Thanormwat Y Kongsiang A. Workshops advocating ASEAN Vaccine Security and Self-Reliance (AVSSR): a regional initiative. Vaccine. 2019;37(14):2034-2041. doi:10.1016\/j.vaccine.2018.05.017","DOI":"10.1016\/j.vaccine.2018.05.017"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.2020529"},{"key":"e_1_3_2_14_2","unstructured":"Ministry of Science Technology and Innovation. The National Vaccine Development Roadmap. Ministry of Science Technology and Innovation. Published December 2023. Accessed August 15 2025. https:\/\/mastic.mosti.gov.my\/publication\/national-vaccine-development-roadmap\/"},{"key":"e_1_3_2_15_2","unstructured":"Ministry of Investment Trade and Industry. New industrial master plan 2030 pharmaceutical industry. Ministry of Investment Trade and Industry. Published September 2023. Accessed August 10 2025. https:\/\/www.nimp2030.gov.my\/nimp2030\/modules_resources\/bookshelf\/e-04-Sectoral_NIMP-Pharmaceutical_Industry\/index.html#page\/1"},{"key":"e_1_3_2_16_2","unstructured":"Wisma Putra. Focus in Continuity: A Framework for Malaysia\u2019s Foreign Policy in a Post-Pandemic World. Ministry of Foreign Affairs Malaysia; 2021. Accessed August 15 2024. https:\/\/fpm.kln.gov.my\/images\/pdf\/eBook_Focus_in_Continuity_Framework.pdf"},{"key":"e_1_3_2_17_2","unstructured":"Pharmaniaga Berhad. Protecting the nation annual report 2020. Pharmaniaga Berhad. Published May 24 2021. Accessed August 15 2024. https:\/\/pharmaniaga.com\/wp-content\/uploads\/2021\/05\/AR-PHARMANIAGA.pdf"},{"key":"e_1_3_2_18_2","unstructured":"Ministry of Science Technology and Innovation (MOSTI) Malaysia. MOSTI channels RM33 mil for 13 vaccine research projects. Official Portal of the Ministry of Science Technology and Innovation. Published November 1 2021. Accessed July 2 2026. https:\/\/www.mosti.gov.my\/"},{"key":"e_1_3_2_19_2","unstructured":"Ministry of Finance Malaysia. Ekonomi MADANI: RM120 billion domestic direct investment boost from Glics under MoF-Led programme. Ministry of Finance Malaysia. Published August 8 2024. Accessed August 28 2024. https:\/\/www.mof.gov.my\/portal\/en\/news\/press-release\/ekonomi-madani-rm120-billion-domestic-direct-investment-boost-from-glics-under-mof-led-programme"},{"key":"e_1_3_2_20_2","unstructured":"Ministry of Finance Malaysia. Budget 2025 Speech: reinvigorating the economy driving reforms prospering the Rakyat. Official Budget Portal of the Ministry of Finance. Published October 18 2024. Accessed July 2 2026. https:\/\/www.mof.gov.my\/"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2022.08.017"},{"key":"e_1_3_2_22_2","unstructured":"Ministry of Science Technology and Innovation Malaysia. Memorandum of Agreement-between the National Institutes of Biotechnology Malaysia and CanSino Biologics Inc People\u2019s Republic of China. Ministry of Science Technology and Innovation Malaysia. Published July 25 2024. Accessed August 28 2024. https:\/\/www.mosti.gov.my\/wp-content\/uploads\/2024\/07\/PR-20240725-MEMORANDUM-OF-AGREEMENT-BETWEEN-THE-NATIONAL-INSTITUTES-OF-BIOTECHNOLOGY-MALAYSIA-AND-CANSINO-BIOLOGICS-INC.-PEOPLES-REPUBLIC-OF-CHINA.pdf"},{"key":"e_1_3_2_23_2","unstructured":"Ministry of Science Technology and Innovation Malaysia. Malaysia renews participation in the Coalition for Epidemic Preparedness Innovations (CEPI). Ministry of Science Technology and Innovation Malaysia. Published August 20 2024. Accessed August 28 2024. https:\/\/www.mosti.gov.my\/en\/berita\/malaysia-memperbaharui-penyertaan-dalam-coalition-for-epidemic-preparedness-innovations-cepi\/"},{"key":"e_1_3_2_24_2","unstructured":"Coalition for Epidemic Preparedness Innovations. CEPI and Universiti Malaya announce new collaboration to advance Nipah virus research. Coalition for Epidemic Preparedness Innovations. Published July 28 2021. Accessed August 28 2024. https:\/\/cepi.net\/cepi-and-universiti-malaya-announce-new-collaboration-advance-nipah-virus-research"},{"key":"e_1_3_2_25_2","unstructured":"International Vaccine Institute. Advancing IVI Malaysia collaboration. LinkedIn. Published August 2024. Accessed August 28 2024. https:\/\/www.linkedin.com\/posts\/international-vaccine-institute_advancing-ivi-malaysia-collaboration-an-activity-7366348761230446592-T0NC\/"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1017\/jme.2023.85"},{"key":"e_1_3_2_27_2","unstructured":"World Economic Forum. Regionalized vaccine manufacturing collaborative. World Economic Forum. Accessed September 2 2025. https:\/\/initiatives.weforum.org\/regionalized-vaccine-manufacturing-collaborative\/home"},{"key":"e_1_3_2_28_2","unstructured":"World Health Organization Regional Office for South-East Asia. Technology Transfer and Intellectual Property Management for Public Health in the Regional Office for South-East Asia. World Health Organization; 2025. Accessed February 2 2026. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/f6a7b9be-ca4e-4799-b649-cee7f681182d\/content"},{"key":"e_1_3_2_29_2","unstructured":"World Bank Group. ASEAN Capacity for Vaccine Research and Development and Production: Malaysia Country Case Study. World Bank Group; 2023. Accessed February 2 2026. https:\/\/openknowledge.worldbank.org\/server\/api\/core\/bitstreams\/07c612c4-f427-45ef-88cf-5c17177530d2\/content"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.24191\/jas.v22i2.3763"},{"key":"e_1_3_2_31_2","unstructured":"Group of 20. G20 Rio de Janeiro Leaders\u2019 declaration. Group of 20. Published November 18 2024. Accessed December 2 2025. https:\/\/g7g20-documents.org\/database\/document\/2024-g20-brazil-leaders-leaders-language-g20-rio-de-janeiro-leaders-declaration-final"}],"container-title":["Asia Pacific Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10105395261481894","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10105395261481894","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10105395261481894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:48:57Z","timestamp":1790095737000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10105395261481894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":30,"alternative-id":["10.1177\/10105395261481894"],"URL":"https:\/\/doi.org\/10.1177\/10105395261481894","relation":{},"ISSN":["1010-5395","1941-2479"],"issn-type":[{"value":"1010-5395","type":"print"},{"value":"1941-2479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"article-number":"10105395261481894"}}